APA Alıntı

Furtado, M., & Rule, S. (2012). Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin’s Lymphoma: Focus on Brentuximab Vedotin. Libertas Academica.

Chicago Stili Alıntı

Furtado, Michelle, ve Simon Rule. Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin’s Lymphoma: Focus On Brentuximab Vedotin. Libertas Academica, 2012.

MLA Alıntı

Furtado, Michelle, ve Simon Rule. Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin’s Lymphoma: Focus On Brentuximab Vedotin. Libertas Academica, 2012.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..